Cargando…

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics

Objectives: As current clinical practice guidelines, ticagrelor is the suggested therapeutic scheme to prevent adverse cardiovascular events in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI) treatment. However, this therapeutic strategy still fails, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Lyu, Peng, Lai, Jinxia, Zhao, Mengzhe, Guo, Jun, Liang, Haibo, Wang, Houfa, Geng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579064/
https://www.ncbi.nlm.nih.gov/pubmed/34776957
http://dx.doi.org/10.3389/fphar.2021.731734

Ejemplares similares